Acute Coronary Syndrome News and Research

RSS

Positive interim data from Anthera's PEARL-SC phase 2b clinical study in systemic lupus erythematosus

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced positive interim biomarker data from the PEARL-SC phase 2b clinical study in patients with systemic lupus erythematosus.

1 Dec 2011

Coronary CTA reveals different heart attack risk scenarios for men and women

Findings on coronary CT angiography (CTA), a noninvasive test to assess the coronary arteries for blockages, show different risk scenarios for men and women, according to a study presented today at the Radiological Society of North America.

30 Nov 2011

Enrollment complete in SUSTAIN Phase 2b clinical trial for atherosclerotic CVD

Resverlogix Corp. today announced that SUSTAIN, a Phase 2b clinical trial comprised of 176 subjects, is fully enrolled.

28 Nov 2011

South Asian patients with CAD more likely to need repeat PCI procedures

South Asian patients with coronary artery disease were almost three times as likely to be readmitted to hospital for further interventional treatment to arterial plaque than their White European counterparts, according to research in the December issue of IJCP, the International Journal of Clinical Practice. They were also more likely to present as an emergency and require urgent treatment.

22 Nov 2011

The Chinese acute coronary syndrome drug market to grow from $326M in 2010 to $448M in 2015

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the acute coronary syndrome (ACS) drug market in China will grow from $326 million in 2010 to $448 million in 2015.

21 Nov 2011

South Asian cardiac patients three times as likely to require repeat treatment following PCI

21 Nov 2011

NYU Langone cardiovascular experts present new research findings at AHA 2011

Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.

18 Nov 2011

Niacin not effective in reducing risk of stroke, heart attack in stable CV patients

In patients whose bad cholesterol is very well-controlled by statins for a long time period, the addition of high-dose, extended release niacin did not reduce the risk of cardiovascular events, including heart attack and stroke.

16 Nov 2011

Xarelto (rivaroxaban) shows success as blood thinner in acute coronary syndrome

A new anti-blood clotting drug – Xarelto (rivaroxaban) has shown clinical success. It may help people with “acute coronary syndrome” lower their risk of death, subsequent heart attack or stroke, a new study finds. Acute coronary syndrome is term that includes people with angina or prior history of heart attack.

15 Nov 2011

Bayer and J&J’s blood thinner drug triumphs at late phase clinical trial

Drug makers Bayer AG and Johnson & Johnson’s new blood clot preventing drug can provide life-saving benefits at very low doses in patients who suffer from acute coronary syndrome finds a new clinical trial.

14 Nov 2011

BIDMC researcher says improvement in survival rates best 'since introduction of aspirin'

An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.

14 Nov 2011

Six-month results from BIOTRONIK's PRO-Kinetic Energy stent study presented at TCT 2011

BIOTRONIK AG announced that the six-month results of the ENERGY Registry were presented last week by Prof. Raimund Erbel at the Transcatheter Cardiovascular Therapeutics (TCT 2011) conference.

14 Nov 2011

UCLA School of Nursing faculty members to present at AHA 2011

A failing heart's effect on the short-term memory. The impact of telephone interventions on behaviors in Latinos. Depression and heart disease. Risk factors contributing to premature coronary atherosclerosis in premenopausal women. These are just a few of the research findings that will be presented by faculty members of the UCLA School of Nursing at the American Heart Association's Scientific Sessions, being held November 12 - 16 in Orlando, FL.

14 Nov 2011

Tailored anti-platelet therapy optimizes treatment for patients wtih common genetic variant

Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) have found.

10 Nov 2011

Miracor's PICSO system safe and feasible during elective PCI

Miracor Medical Systems announced today that data will be reported during next week's "TCT (Transcatheter Cardiovascular Therapeutics) 2011" scientific meeting in San Francisco.

5 Nov 2011

Role of cardiovascular magnetic resonance in clinical cardiology

Cardiovascular Magnetic Resonance (CMR) has undergone substantial development and offers important advantages compared with other well-established imaging modalities.

3 Nov 2011

Active partnership between patient and healthcare professionals can reduce hospital stay

Healthcare that implements a person-centred approach not only make care more efficient, but also yields more satisfied patients. A study carried out at the Sahlgrenska Academy at the University of Gothenburg, Sweden, shows that if there is an active partnership between the patient and healthcare professionals, the patient's hospital stay can be reduced by one-third.

2 Nov 2011

Scripps researcher receives U-M's Eric J. Topol Professorship in Cardiovascular Medicine

The University of Michigan Medical School today announced the establishment of the Eric J. Topol Professorship in Cardiovascular Medicine. A world-renowned cardiologist, Dr. Topol is currently chief academic officer at Scripps Health and a senior cardiologist practitioner at Scripps Clinic.

27 Oct 2011

Effective liability reform could reduce hospital admissions

Visits to emergency departments climbed nearly 10 percent in one year to a new high of more than 136 million visits in 2009, according to preliminary estimates from the Centers for Disease Control and Prevention (CDC), just as emergency physicians are releasing new studies showing an association between medical liability concerns and rising hospital admissions from the emergency department.

18 Oct 2011

ESC to deliver educational programme on cardiovascular disease in Beijing

At over 40%, the mortality rate due to cardiovascular disease (CVD) in China is amongst the highest in the world- and has been rightly described as an epidemic. Its population faces a catalogue of CVD risk factor statistics that expose high levels of obesity, diabetes, cholesterol and blood pressure, and a smoking habit within males that is proving stubborn to address.

13 Oct 2011

Acute Coronary Syndrome News and Research

Positive interim data from Anthera's PEARL-SC phase 2b clinical study in systemic lupus erythematosus

Coronary CTA reveals different heart attack risk scenarios for men and women

Enrollment complete in SUSTAIN Phase 2b clinical trial for atherosclerotic CVD

South Asian patients with CAD more likely to need repeat PCI procedures

The Chinese acute coronary syndrome drug market to grow from $326M in 2010 to $448M in 2015

South Asian cardiac patients three times as likely to require repeat treatment following PCI

NYU Langone cardiovascular experts present new research findings at AHA 2011

Niacin not effective in reducing risk of stroke, heart attack in stable CV patients

Xarelto (rivaroxaban) shows success as blood thinner in acute coronary syndrome

Bayer and J&J’s blood thinner drug triumphs at late phase clinical trial

BIDMC researcher says improvement in survival rates best 'since introduction of aspirin'

Six-month results from BIOTRONIK's PRO-Kinetic Energy stent study presented at TCT 2011

UCLA School of Nursing faculty members to present at AHA 2011

Tailored anti-platelet therapy optimizes treatment for patients wtih common genetic variant

Miracor's PICSO system safe and feasible during elective PCI

Role of cardiovascular magnetic resonance in clinical cardiology

Active partnership between patient and healthcare professionals can reduce hospital stay

Scripps researcher receives U-M's Eric J. Topol Professorship in Cardiovascular Medicine

Effective liability reform could reduce hospital admissions

ESC to deliver educational programme on cardiovascular disease in Beijing

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News